Emerging treatments for progressive myoclonus epilepsies.

Expert Review of Neurotherapeutics
Antonella RivaPasquale Striano

Abstract

Introduction: Progressive myoclonus epilepsies (PMEs) are a group of neurodegenerative diseases, invariably leading to severe disability or fatal outcome in a few years or decades. Nowadays, PMEs treatment remains challenging with a significant burden of disability for patients. Pharmacotherapy is primarily used to treat seizures, which impact patients' quality of life. However, new approaches have emerged in the last few years, which try to curb the neurological deterioration of PMEs through a better knowledge of the pathogenetic process. This is a review on the newest therapeutic options for the treatment of PMEs.Areas covered: Experimental and clinical results on novel therapeutic approaches for the different forms of PME are reviewed and discussed. Special attention is primarily focused on the efficacy and tolerability outcomes, trying to infer the role novel approaches may have in the future.Expert opinion: The large heterogeneity of disease-causing mechanisms prevents researchers from identifying a single approach to treat PMEs. Understanding of pathophysiologic processes is leading the way to targeted therapies, which, through enzyme replacement or underlying gene defect correction have already proved to potentially stri...Continue Reading

References

Jul 17, 1998·The Journal of Clinical Investigation·A K DasS L Hofmann
Oct 12, 2000·The Journal of Biological Chemistry·M TyagiM Giacca
Sep 22, 2001·Protein Science : a Publication of the Protein Society·S HakanssonM Caffrey
Jul 18, 2002·Nature Reviews. Drug Discovery·Matthias K Schwarz, Timothy N C Wells
Sep 25, 2002·Neurology·Thomas R Henry
Dec 4, 2003·Epilepsia·Ilo E Leppik
Jun 24, 2004·Journal of Neuroscience Research·Clara M ChengCarolyn A Bondy
Apr 12, 2005·Neuroscience and Biobehavioral Reviews·Duncan A Groves, Verity J Brown
Mar 1, 2006·Epilepsy Research·Simonetta CardinaliPierangelo Veggiotti
Feb 8, 2008·Nature Clinical Practice. Neurology·Pasquale StrianoBerge A Minassian
Aug 23, 2008·Epilepsia·Véronique RibanMatthew J During
Feb 7, 2009·Seizure : the Journal of the British Epilepsy Association·Natacha PortaStéphane Auvin
Mar 17, 2009·Brain Research·Yuka SuzukiEiichi Ishii
Aug 3, 2010·Journal of Neurosurgery. Pediatrics·Mark M SouweidaneMichael G Kaplitt
Dec 8, 2010·Nature Reviews. Neurology·Annamaria VezzaniTallie Z Baram
Sep 22, 2011·Wiley Interdisciplinary Reviews. RNA·John W YarhamRobert W Taylor
Sep 25, 2012·Seizure : the Journal of the British Epilepsy Association·Ayataka FujimotoTakamichi Yamamoto
Dec 12, 2012·Surgical Neurology International·Scott E Krahl, Kevin B Clark
Jan 31, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·B BonazD Clarençon
Feb 15, 2013·Pharmacogenetics and Genomics·Yogita Ghodke-PuranikTeri E Klein
Feb 15, 2013·JAMA Neurology·Svjetlana MiocinovicJerrold L Vitek
Apr 16, 2013·Journal of Neurosurgery. Pediatrics·Nathan R SeldenRobert D Steiner
Oct 1, 2013·Epilepsy Research·Vincenzo BelcastroAlberto Verrotti
Jan 5, 2014·Neurology·Silvana FranceschettiUNKNOWN Collaborative LICE study group on PMEs
Apr 9, 2014·Nature Reviews. Neurology·Robert S Fisher, Ana Luisa Velasco
May 9, 2014·Frontiers in Neurology·Carmela GiordanoGiuseppe Biagini
Jul 16, 2014·Nature Reviews. Genetics·Hao YinDaniel G Anderson
Jul 31, 2014·International Reviews of Immunology·Wei GeXuetao Cao
Jan 1, 2013·Epilepsy & Behavior Case Reports·Sanja HajnsekAndreja Bujan Kovac
Apr 8, 2015·Epilepsy & Behavior : E&B·Marco MulaTim J von Oertzen
Sep 1, 2015·Annals of Physical and Rehabilitation Medicine·Wanalee KlomjaiAlexandra Lackmy-Vallée
Nov 29, 2015·Neurosurgery Clinics of North America·Vibhor KrishnaRichard Wennberg
Dec 22, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marianna FoldvariAmirreza Rafiee
Nov 3, 2016·Annals of Neurology·Amy AldrichTammy Kielian
Jan 10, 2017·Expert Opinion on Pharmacotherapy·Pasquale Striano, Vincenzo Belcastro

❮ Previous
Next ❯

Citations

Mar 28, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Abolfazl YariNasrollah Saleh-Gohari
Apr 14, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Antonella Riva, Pasquale Striano
Oct 12, 2021·Expert Review of Neurotherapeutics·Ana PejčićMiloš Milosavljević

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Neurotherapeutics
Shweta Bhat, Subramaniam Ganesh
Current Pharmaceutical Design
Edoardo FerlazzoBerge A Minassian
Seizure : the Journal of the British Epilepsy Association
Alessandro OrsiniPasquale Striano
International Journal of Biological Macromolecules
Mélanie L'EnfantCorinne Pau-Roblot
© 2021 Meta ULC. All rights reserved